Microbiology Spectrum · 2024 · 19 citations · 31 references
Life SciencesBiotechnologyMolecular GeneticsGenomicsMolecular DiagnosticsVirologyCancer Molecular DiagnosticsCervical CancerCrispr-cas SystemsEarly Cancer DetectionNucleic Acid Amplification TestingPolymerase Chain ReactionCervical Cancer ScreeningCrispr-based Molecular DiagnosticsHigh-risk Human Papillomavirus TypesHpv Molecular DiagnosticsIsothermal Amplification AssaysMultiplex Detection AssaysMultiplex Nucleic Acid DetectionRapid Detection Assays
Persistent infection with high-risk human papillomavirus (HR-HPV) is the principal etiological factor of cervical cancer. Considering the gradual progression of cervical cancer, the early, rapid, sensitive, and specific identification of HPV, particularly HR-HPV types, is crucial in halting the advancement of the illness. Here, we established a rapid, highly sensitive, and specific HR-HPV detection platform, leveraging the CRISPR/Cas12a assay in conjunction with multienzyme isothermal rapid amplification. Our platform enables the detection and genotyping of 14 types of HR-HPV by using type-specific crRNAs. The outcomes of the detection can be interpreted either through a fluorescence reader or visually. Furthermore, we achieved one-tube multiplex detection of 14 HR-HPV types through the use of multiple amplifications and a crRNA pool. The detection sensitivity of this method is 2 copies/μL with no cross-reactivity, and the results can be obtained within 30 minutes. This method exhibited 100% clinical sensitivity and 100% clinical specificity when applied to 258 clinical specimens. Based on these findings, our CRISPR/Cas-based HR-HPV detection platform holds promise as a novel clinical detection tool, offering a visually intuitive and expedited alternative to existing HPV infection diagnostics and providing fresh perspectives for clinical cervical cancer screening.IMPORTANCEThis study developed a novel high-risk human papillomavirus (HR-HPV) detection platform based on CRISPR/Cas12a technology. This platform not only enables the rapid, highly sensitive, and specific detection and genotyping of 14 types of HR-HPV but also achieves single-tube multiplex detection of 14 HR-HPV types through ingenious design. The outcomes of the detection can be interpreted either through a fluorescence reader or visually. To the best of our knowledge, this is the first paper to utilize CRISPR/Cas diagnostic technology for the simultaneous detection of 14 types of HPV and to evaluate its feasibility in clinical sample detection using a large number of clinical samples. We hope that this work will facilitate the rapid and accurate detection of HPV and promote the broader application of CRISPR/Cas diagnostic technology.
31
SHERLOCK: nucleic acid detection with CRISPR nucleases
Max J. Kellner, Jeremy Koob, Jonathan S. Gootenberg et al. · Nature Protocols · 2019 · 1.6K citations · Full text
Deependra Singh, Jérôme Vignat, Valentina Lorenzoni et al. · The Lancet Global Health · 2022 · 1.5K citations · Full text
CRISPR-Cas12a-assisted nucleic acid detection
Shiyuan Li, Qiuxiang Cheng, Jing-Man Wang et al. · Cell Discovery · 2018 · 1.5K citations · Full text
Field-deployable viral diagnostics using CRISPR-Cas13
Cameron Myhrvold, Catherine A. Freije, Jonathan S. Gootenberg et al. · Science · 2018 · 1.5K citations · Full text